YOLO, FOMO, whatever, @volf, I think this is headed higher.
Cryosite might be ranked in the 'speccy' end of town but this stock is no longer a speccy.
It's emerging as a conservatively-run 'blue chip', with blue chip international clients.
It's pivotably-placed in a burgeoning TGA-moated health-medical space.
Your reference to 'medtech' is apt.
The group is now realizing potential by offering real-time data as a service to clients.
Revisiting the Interim Report and noting comments in the CTE Buy-Out reversal announcement, I'm forecasting a full year's turnover of near $11m and balance date cash approaching $5m.
Final results due towards the end of August will tell whether CTE is worthy of notching record highs.
CTE Price at posting:
33.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)